CClinicalTrials.gg
CompletedNCT02939690Updated May 2, 2018

Umbilical Venous Catheter Insertion Depth in Neonates

An interventional study of UVC and UVC in Central Venous Catheterization, sponsored by University of Calgary. Completed at 1 site in Canada. Open to participants aged 1 Minute to 2 Weeks. Per ClinicalTrials.gov, last updated 2018-05-02.

Sponsored by University of Calgary · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
1 Minute to 2 Weeks
Sex
All
01

Study summary

In this randomized clinical study, neonates who require umbilical venous catheter (UVC) insertion as part of their routine care at anytime during their NICU admission will be randomized to one of the 2 formulas for estimation of the pre-insertion UVC depth (umbilicus to the nipple in cm minus 1 (UN - 1) or birth weight based formula ([(3× birth weight (Kg) + 9)/2+1)]. UVC will be inserted under sterile condition as per unit protocol. To verify the UVC tip position, a thoracoabdominal radiograph will be taken. In addition, the investigators will do a ultrasound of the heart to assess the exact location of the catheter tips as soon as possible but within 6 hours of insertion.

Read the detailed description

Background:

The ideal position of UVC) tip to minimize complications is just outside the heart at the junction of inferior vena cava and right atrium. UVC related complications are mainly due to catheter malposition. Accurate prediction of insertion length of UVC as well as confirmation of the position after insertion by radiograph or with ultrasound is very important to avoid complications. UVC malposition with subsequent re-positioning exposes these fragile infants to unnecessary handling, further radiologic exposure and increasing risk of infection.

The commonly used formulas to estimate the depth of umbilical catheter include Dunn's shoulder to umbilical length graph and a birth weight based formula proposed by Shukla and Ferrara in 1986. In Calgary, the most commonly used method for estimation of UVC insertion length is the birth weight based formula (i.e. UVC insertion length = (3 x birth weight + 9)/2 +1). The success rate of achieving the optimum position of catheter tip using this formula ranges from 31-40%. A recent retrospective study reported the use of different surface markers for calculating UVC insertion depth. A distance from base of umbilicus to nipple distance (UN)-1 cm provided the best and most accurate insertion depth of UVC. This formula had accuracy rate of 84% compared with 57% accuracy rate with birth weight based formula.

The objectives of our study are:

  1. To compare accuracy rate between UVC insertion length estimated by using two formula (i.e. umbilicus to the nipple distance in cm minus 1 (UN - 1) and Shukla's birth weight based formula ([(3× birth weight (Kg) + 9)/2+1)] in achieving optimum UVC tip position
  2. To compare the accuracy rate of UVC tip position between two methods based on growth status of neonates

Methods:

This is a randomized clinical study. All infants who require UVC insertion as part of their routine care at anytime during their hospital admission are eligible for the study. Infants with hydrops fetalis, abdominal wall defects, congenital diaphragmatic hernia and/or major structural heart disease will be excluded from the study.

When a newborn baby needs UVC central line insertion, neonate will be randomized to one of the 2 formulas for estimation of the pre-insertion UVC depth. UVC will be inserted under sterile condition as per unit protocol. To verify the UVC tip position, a thoracoabdominal radiograph will be taken. In addition,the investigators will do a ultrasound of the the heart to assess the exact location of the catheter tips as soon as possible but within 6 hours of insertion.

02

Conditions studied

  • Central Venous Catheterization

Keywords

  • Catheter
  • Umbilical vein
  • Neonate
03

In context

Lead sponsor

University of Calgary is the lead sponsor of 686 studies on the registry; 189 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Minute to 2 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All infants who require UVC insertion as part of their routine care at anytime during their NICU admission

Exclusion criteria

Exclusion Criteria:

  • Infants with hydrops fetalis, infants with abdominal wall defects, congenital diaphragmatic hernia and major structural heart disease
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    UVC and surface measurement formula

    UVC insertion depth = Umbilicus to nipple distance minus 1cm

    Device: UVC · Device: Ultrasound

  • Active comparator
    UVC and Birth weight based formula

    UVC insertion depth=\[(3× birth weight (Kg) + 9)/2+1)\] cm

    Device: UVC · Device: Ultrasound

Interventions

  • DeviceUVC

    UVC insertion depth calculated by \[(3× birth weight (Kg) + 9)/2+1)\]

    Also known as: UVC insertion using birth weight based calculation

  • DeviceUVC

    UVC insertion depth calculated by umbilicus to nipple distance-1

    Also known as: UVC insertion using surface measurement

  • DeviceUltrasound

    Also known as: Ultrasound assessment of UVC

06

What researchers measure

Primary outcomes

  1. Proportion of correctly inserted UVC at optimum catheter tip position

    Time frame: within 12 hours

Secondary outcomes

  1. Number of readjustment of UVC

    Time frame: within first 2 weeks

  2. Comparison of UVC tip position between two methods based on based growth status at birth (i.e.AGA, SGA, LGA)

    AGA: appropriate for gestational age (i.e birth weight between 10th and 90th percentile for gestational age); SGA: Small for gestational age (i.e. birth weight \<10th percetile for gestational age); LGA: large for gestational age (i.e.birth weight \>90th percentile for gestational age) using Fentons growth chart for preterm infants and WHO growth chart for term infants

    Time frame: within 12 hours

07

Study locations

1 site
  • Foothills Medical Center
    Calgary, Alberta T2N 2T9, Canada
08

References and documents

Publications

  • Shukla H, Ferrara A. Rapid estimation of insertional length of umbilical catheters in newborns. Am J Dis Child. 1986 Aug;140(8):786-8. doi: 10.1001/archpedi.1986.02140220068034. PubMed 3728405 ↗
  • Gupta AO, Peesay MR, Ramasethu J. Simple measurements to place umbilical catheters using surface anatomy. J Perinatol. 2015 Jul;35(7):476-80. doi: 10.1038/jp.2014.239. Epub 2015 Jan 22. PubMed 25611793 ↗
  • Kieran EA, Laffan EE, O'Donnell CP. Estimating umbilical catheter insertion depth in newborns using weight or body measurement: a randomised trial. Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F10-5. doi: 10.1136/archdischild-2014-307668. Epub 2015 Aug 11. PubMed 26265678 ↗
  • Harabor A, Soraisham A. Rates of intracardiac umbilical venous catheter placement in neonates. J Ultrasound Med. 2014 Sep;33(9):1557-61. doi: 10.7863/ultra.33.9.1557. PubMed 25154935 ↗
  • Michel F, Brevaut-Malaty V, Pasquali R, Thomachot L, Vialet R, Hassid S, Nicaise C, Martin C, Panuel M. Comparison of ultrasound and X-ray in determining the position of umbilical venous catheters. Resuscitation. 2012 Jun;83(6):705-9. doi: 10.1016/j.resuscitation.2011.11.026. Epub 2011 Dec 6. PubMed 22155219 ↗
  • Dunn PM. Localization of the umbilical catheter by post-mortem measurement. Arch Dis Child. 1966 Feb;41(215):69-75. doi: 10.1136/adc.41.215.69. No abstract available. PubMed 5906629 ↗
  • Sheta A, Kamaluddeen M, Soraisham AS. Umbilical venous catheter insertion depth estimation using birth weight versus surface measurement formula: a randomized controlled trial. J Perinatol. 2020 Apr;40(4):567-572. doi: 10.1038/s41372-019-0456-0. Epub 2019 Aug 5. PubMed 31383945 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02939690
Lead sponsor
University of Calgary
Responsible party
Amuchou Soraisham (Associate Professor of Pediatrics, University of Calgary) — Principal investigator
First posted
Oct 20, 2016
Start date
Oct 2016
Primary completion
Mar 2018
Completion
Mar 2018
Last update
May 2, 2018

Study contacts

Amuchou S Soraisham, MD, DM,
principal investigator · University of Calgary

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion